This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. This issue profiles a drug for oculopharyngeal muscular dystrophy treatment that receives orphan drug designation; non-viral CFTR-based gene therapy for cystic fibrosis patients, a breast cancer diagnostic test in Europe.

    $250.00
  2. This issue profiles a novel microchip-enabled drug-delivery system, a technology for reducing diesel engine emissions, and head-up displays that get transformed into consumer wearables.

    $250.00
  3. This issue profiles miotoxicity and drug screening assays through micropatterning techniques, leveraging glycobioengineering for cancer research, and pharmacological chaperones to enhance enzyme replacement therapies.

    $950.00
  4. This issue profiles a biomarker for detection of mental disorders in women, a novel gene-control molecule that targets chronic wounds, and gene therapy for treatment of Parkinson’s disease.

    $250.00
  5. This issue profiles a novel genetic approach to target pancreatic cancer tumor and regrowth, a study to identity genetic receptor changes related to HIV treatment, a study to identity gene types responsible for varying sleep patterns.

    $250.00
  6. This issue profiles a novel indicator for breast cancer screening, a next generation behavioral health platform, and a diagnostic and therapeutic PET imaging agent

    $950.00
  7. This issue profiles a sound wave-based point of care diagnostic device for biomarker detection, a novel methodology to detect antiviral antibody interactions, and placenta-on-a-chip technology for understanding placental function

    $250.00
  8. This issue profiles an injectable drug eluting bone substitute for bone healing and remodelling, an innovative image acquisition platform that boosts medical sonography capabilities, and a drug-eluting biodegradable scaffold for percutaneous coronary intervention.

    $950.00
  9. This issue profiles 3D bioprinting for breast cancer reconstruction of nipple areola complex, enablement of cardiovascular tissue using extracellular matrix-based technology, and a experimental technique for development of whole organs

    $250.00
  10. This issue profiles a submental contouring injectable drug that has been approved by FDFA, treatment for irritable bowel syndrome that has obtained FDA approval, and a strategic procedure to prepare more reliable antibody drug conjugates.

    $950.00